Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab
暂无分享,去创建一个
I. Lowy | T. D. de Gruijl | K. Jooss | S. Santegoets | R. Scheper | W. Gerritsen | S. Lougheed | A. V. D. van den Eertwegh | H. Gall | K. Hege | A. Stam | N. Sacks